Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000582397 | SCV000688235 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001482366 | SCV001686732 | likely benign | Juvenile polyposis syndrome | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000582397 | SCV002689544 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomic Medicine, |
RCV003321689 | SCV004027593 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV001482366 | SCV005405385 | benign | Juvenile polyposis syndrome | 2024-08-07 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
All of Us Research Program, |
RCV001482366 | SCV005425418 | likely benign | Juvenile polyposis syndrome | 2024-08-06 | criteria provided, single submitter | clinical testing |